Start an analysis for INGN
Inogen Inc
Stock · NASDAQProgram summary
| Field | Value | As of | Source |
|---|---|---|---|
| Current authorization | $45m | 30-Sep-26 | 10-Q filed 09-Nov-26 |
| Remaining authorization | $19m | 30-Sep-26 | 10-Q filed 09-Nov-26 |
| Program expiry | 30-Jun-28 | 30-Sep-26 | 10-Q filed 09-Nov-26 |
| Repurchased last quarter | $4m | 30-Sep-26 | 10-Q filed 09-Nov-26 |
| Has used an ASR | No | — |
Programs
| Authorized on | Authorized | Remaining | Expires | Terms |
|---|---|---|---|---|
| 28-Sep-26 | $45m | $19m | 30-Jun-28 | On September 28, 2026, our Board of Directors approved an amendment to increase the aggregate repurchase authorization to $45.0 million and to extend the program's expiration date from December 31, 2027 to June 30, 2028.10-Q filed 09-Nov-26 |
Open-market repurchases
- Jul ’26
- Aug ’26
- Sep ’26
| Month ended | Shares | Avg price | ≈ Value | Source |
|---|---|---|---|---|
| 30-Sep-26 | 237,000 | $5.27 | $1m | 10-Q filed 09-Nov-26 |
| 31-Aug-26 | 212,600 | $5.88 | $1m | 10-Q filed 09-Nov-26 |
| 31-Jul-26 | 192,100 | $6.50 | $1m | 10-Q filed 09-Nov-26 |